首页> 外文期刊>Academic radiology >Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI. Reasons, Rates, and Outcomes
【24h】

Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI. Reasons, Rates, and Outcomes

机译:3.0 T MRI确定MRI引导乳房活组织检查的可疑乳腺病变。 原因,汇率和结果

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale and Objectives: To determine the cancelation rate of magnetic resonance imaging (MRI)-guided procedures in suspicious breast lesions initially detected at 3.0 Tesla (T) MRI. Materials and Methods: With institutional review board approval, a Health Insurance Portability and Accountability Act-compliant retrospective review of 117 suspicious 3.0 T MRI-detected lesions in 101 patients scheduled to undergo MRI-guided procedures was performed; informed consent was waived. Patient information, imaging features, and outcome data were collected and compared among completed and canceled procedures using Fisher's exact test. Results: MRI-guided breast biopsies were canceled in 13% (15/117) because of lesion nonvisualization, including three (20%) masses, one (1%) focus, and 11 (73%) areas of nonmasslike enhancement. Median lesion size was 1.1 cm. Sixty percent (9/15) of nonvisualized lesions were associated with minimal or mild background parenchymal enhancement at MRI. The nonvisualization rate was not associated with patient age, menopausal status, lesion type, size, breast density, or background parenchymal enhancement (P > .7 for each). No cancers were detected at original lesion sites in 14 (93%) patients undergoing follow-up imaging (n = 11) or mastectomy (n = 3) for cancer elsewhere; one (7%) was lost to follow-up. Conclusion: The MRI-guided breast biopsy cancelation rate from nonvisualization of suspicious lesions originally detected with 3.0 T MRI scanning was 13%, similar to rates reported for lesions detected at 1.0 and 1.5 T MRI. No cancers were detected on follow-up imaging. Canceling MRI-guided biopsies because of lesion nonvisualization is a reasonable approach if measures are taken to ensure lesion resolution at the time of biopsy and at imaging follow-up. ? 2013 AUR.
机译:理由和目标:确定最初检测到3.0特斯拉(T)MRI最初检测到可疑乳房病变中的磁共振成像(MRI)导液的取消率。材料和方法:通过机构审查委员会批准,符合健康保险便携性和问责制行为的回顾审查117名可疑3.0患者在预定进行MRI引导程序的101名患者中进行的117个可疑3.0 T MRI检测的病灶;被告知同意。收集患者信息,成像特征和结果数据,并在使用Fisher确切的测试中进行完成和取消的程序进行比较。结果:由于病变非血管化,包括三(20%)群体,1(1%)焦点,11(73%)的非乳种增强区域,其中MRI引导乳房活组织检查是取消的13%(15/117)。中位数病变尺寸为1.1厘米。 60%(9/15)的非智能病变与MRI的最小或温和的背景实质增强有关。非增长率与患者年龄,更年期状态,病变型,大小,乳房密度或背景实质增强(每次p> .7)无关。在别处进行后续成像(n = 11)或乳房切除术(n = 3)的14例(93%)患者的原始病变部位没有检测到癌症的癌症。一个(7%)失去了随访。结论:来自3.0 T MRI扫描最初检测到的可疑病变的非血管活检消除率的MRI引导乳房活检取消率为13%,类似于在1.0和1.5 T MRI检测到病变的报告率。在随访成像上没有检测癌症。取消MRI引导的活组织检查由于病变NonVisualization是一种合理的方法,如果采取措施,以确保活组织检查时间和成像随访时的病变分辨率。还2013年AUR。

著录项

  • 来源
    《Academic radiology》 |2013年第5期|共7页
  • 作者单位

    Department of Diagnostic Radiology Duke University Medical Center DUMC 3808 Durham NC 27710;

    Department of Diagnostic Radiology Duke University Medical Center DUMC 3808 Durham NC 27710;

    Department of Radiology University of Chapel Hill Medical Center Chapel Hill NC 27599 United;

    Department of Diagnostic Radiology Duke University Medical Center DUMC 3808 Durham NC 27710;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

    Biopsy; Breast; Mammogram;

    机译:活组织检查;乳房;乳房X光检查;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号